A new nanomedicine group has landed at the Catalan Institute of Nanoscience and Nanotechnology (ICN2) as a culmination of a process that started years ago and brings to the ICN2 an influential researcher with a profound impact in the translation of carbon nanomaterials, such as graphene, into pharmaceuticals, biotech and medical devices, together with his know-how and network of international connections. This new group is being directed by Dr. Neus Lozano as senior postdoc under the Flagship Project.